Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) (USD $)	3 Months Ended		314 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012
REVENUES			$ 133,349
EXPENSES
Cost of sales			103,790
General and administrative	1,329,766	211,304	20,689,417
Research and development	68,249	282,579	5,174,177
Expense on extension of warrants			2,092,315
Depreciation and amortization	7,861	5,045	90,915
Bad debt expense			48,947
Total Expenses	1,405,876	498,928	28,199,561
Loss from Operations	(1,405,876)	(498,928)	(28,066,212)
OTHER INCOME (EXPENSES)
Gain on sale of subsidiaries			208,417
Debt forgiveness			61,514
Non-controlling interest in loss			26,091
Other income			19,780
Interest expense	(6,185)	(6,264)	(1,172,686)
Loss on termination of license agreement			(125,000)
Total Other Expenses	(6,185)	(6,264)	(981,884)
LOSS BEFORE EXTRAORDINARY ITEMS	(1,412,061)	(505,192)	(29,048,096)
EXTRAORDINARY ITEMS
Debt forgiveness			479,738
Lawsuit settlement			415,000
Total Extraordinary Items			894,738
NET LOSS	(1,412,061)	(505,192)	(28,153,358)
OTHER COMPREHENSIVE LOSS
Loss on foreign currency translation	(908)	(2,106)	(21,990)
TOTAL COMPREHENSIVE LOSS	$ (1,412,969)	$ (507,298)	$ (28,175,348)
BASIC LOSS PER SHARE (in Dollars per share)	$ 0.00	$ 0.00
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING (in Shares)	277,646,110	259,672,606